Learned multi-omics panel is evaluated against pediatric pneumonia severity
Source check: Source checked. Not independent scientific confirmation.
Finding: A learned eight-feature panel combined five protein and three metabolite measurements to distinguish mild from severe pediatric pneumonia. The source reports an ROC area of 0.82 in a further 50 clinical samples. This is severity-label discrimination, not mortality prediction, a demonstrated early forecast or a treatment effect.
Technology: Random-forest feature ranking; logistic regression
Publication: Peer-reviewed paper · Test context: retrospective or benchmark. Catalog categories, not an evidence grade.
- AI contribution
- The Results attribute feature ranking to a random-forest model, while the Methods describe the selected five-protein/three-metabolite panel entering a logistic classifier. AI credit is limited to learned panel nomination/evaluation, not pathways or treatment mechanisms.
- Test and result
- Initial recruitment comprised 57 affected children and 10 healthy controls. The source describes a 70:30 development/test split and a separate 50-sample clinical validation for the severity panel, with reported AUC 0.82.
- Limitation / still unknown
- Exact model ordering differs between Results and Methods and is not fully reconciled. Matched multi-omics sample counts, repeated-sample independence and additional cohort timing/composition are incompletely specified in reviewed passages. Some redundancy filtering is described before the split. Validation is retrospective and single-centre, not an established independently frozen clinical test. A heading mentions mortality, but modeled labels are mild versus severe disease. Operational laboratory/pathogen procedures were not inspected.
Evidence sources and annotation context
Evidence context (descriptions follow the cited sources; test type is a catalog classification):
Evidence sources: https://pmc.ncbi.nlm.nih.gov/articles/PMC12925244/ · https://doi.org/10.1016/j.isci.2026.114861
Source checked · editorial details
The source page was checked against this entry. Independent confirmation is not assessed by this label.
Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.
Review date: 21 Nov 2026. Review scope: Original selected computational/clinical or physical Methods, model role, specific Results and limitations read; operational biological sections excluded.
No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.
Editorial assessment: Impact 1/5 · Validation 2/5 · Novelty 2/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.